Omada Health (OMDA) announced the appointment of Thomas Tsang, MD, MPH as Chief Medical Officer. Dr. Tsang brings extensive experience in academia, clinical care delivery, and health information technology. In this role, he will lead Omada’s clinical organization while advancing clinical quality, outcomes, strategy, and innovation across Omada’s multi-condition platform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMDA:
- Omada Health price target raised to $28 from $24 at Barclays
- Omada Health’s Surge in App Downloads and GLP-1 Care Track Expansion Justify Buy Rating
- Omada Health added to ‘Tactical Outperform’ list at Evercore ISI
- Omada Health launches “Meal Map” AI-powered nutrition tool
- Omada Health announces analysis on weight maintenance post GLP-1 discontinuation